Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation

Carles Morte, Carles Celma, Christian De Geyter, J. Urbancsek, Buenaventura Coroleu Lletget, Barbara Cometti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Problem: Gonadotrophin hormones are used for the controlled ovarian stimulation (COS) as part of the in vitro fertilization techniques. Therapeutic proteins have the potential to induce an unwanted immune response. Method of study: The presence of anti-FSH, anti-LH and anti-hCG antibodies were determined in patients from two different clinical trials after the repeated administration of hMG or FSH. Results: In the first study, 27 subjects were screening for the presence of anti-FSH antibodies. From the 27 patients, only one patient showed the presence of low levels of antibodies. In a second study, 25 patients were screened for the presence of anti-FSH, anti-LH and anti-hCG antibodies. At the end of the study, no patients showed the presence of antibodies. Conclusion: The results of this study suggest that repeated treatment cycles with FSH or hMG in patients undergoing COS for in vitro fertilization can be safely and effectively applied without concerns for immunogenicity.

Original languageEnglish
Article numbere12675
JournalAmerican Journal of Reproductive Immunology
Volume78
Issue number3
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Ovulation Induction
Gonadotropins
Anti-Idiotypic Antibodies
Fertilization in Vitro
Antibodies
Clinical Trials
Hormones
Therapeutics
Proteins

Keywords

  • ADA
  • antibodies
  • FSH
  • hCG
  • LH

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation. / Morte, Carles; Celma, Carles; De Geyter, Christian; Urbancsek, J.; Coroleu Lletget, Buenaventura; Cometti, Barbara.

In: American Journal of Reproductive Immunology, Vol. 78, No. 3, e12675, 01.09.2017.

Research output: Contribution to journalArticle

Morte, Carles ; Celma, Carles ; De Geyter, Christian ; Urbancsek, J. ; Coroleu Lletget, Buenaventura ; Cometti, Barbara. / Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation. In: American Journal of Reproductive Immunology. 2017 ; Vol. 78, No. 3.
@article{3c4c9ab734a747a98bbd6c7d0c6b0dd4,
title = "Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation",
abstract = "Problem: Gonadotrophin hormones are used for the controlled ovarian stimulation (COS) as part of the in vitro fertilization techniques. Therapeutic proteins have the potential to induce an unwanted immune response. Method of study: The presence of anti-FSH, anti-LH and anti-hCG antibodies were determined in patients from two different clinical trials after the repeated administration of hMG or FSH. Results: In the first study, 27 subjects were screening for the presence of anti-FSH antibodies. From the 27 patients, only one patient showed the presence of low levels of antibodies. In a second study, 25 patients were screened for the presence of anti-FSH, anti-LH and anti-hCG antibodies. At the end of the study, no patients showed the presence of antibodies. Conclusion: The results of this study suggest that repeated treatment cycles with FSH or hMG in patients undergoing COS for in vitro fertilization can be safely and effectively applied without concerns for immunogenicity.",
keywords = "ADA, antibodies, FSH, hCG, LH",
author = "Carles Morte and Carles Celma and {De Geyter}, Christian and J. Urbancsek and {Coroleu Lletget}, Buenaventura and Barbara Cometti",
year = "2017",
month = "9",
day = "1",
doi = "10.1111/aji.12675",
language = "English",
volume = "78",
journal = "American Journal of Reproductive Immunology",
issn = "8755-8920",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Assessment of the immunogenicity of gonadotrophins during controlled ovarian stimulation

AU - Morte, Carles

AU - Celma, Carles

AU - De Geyter, Christian

AU - Urbancsek, J.

AU - Coroleu Lletget, Buenaventura

AU - Cometti, Barbara

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Problem: Gonadotrophin hormones are used for the controlled ovarian stimulation (COS) as part of the in vitro fertilization techniques. Therapeutic proteins have the potential to induce an unwanted immune response. Method of study: The presence of anti-FSH, anti-LH and anti-hCG antibodies were determined in patients from two different clinical trials after the repeated administration of hMG or FSH. Results: In the first study, 27 subjects were screening for the presence of anti-FSH antibodies. From the 27 patients, only one patient showed the presence of low levels of antibodies. In a second study, 25 patients were screened for the presence of anti-FSH, anti-LH and anti-hCG antibodies. At the end of the study, no patients showed the presence of antibodies. Conclusion: The results of this study suggest that repeated treatment cycles with FSH or hMG in patients undergoing COS for in vitro fertilization can be safely and effectively applied without concerns for immunogenicity.

AB - Problem: Gonadotrophin hormones are used for the controlled ovarian stimulation (COS) as part of the in vitro fertilization techniques. Therapeutic proteins have the potential to induce an unwanted immune response. Method of study: The presence of anti-FSH, anti-LH and anti-hCG antibodies were determined in patients from two different clinical trials after the repeated administration of hMG or FSH. Results: In the first study, 27 subjects were screening for the presence of anti-FSH antibodies. From the 27 patients, only one patient showed the presence of low levels of antibodies. In a second study, 25 patients were screened for the presence of anti-FSH, anti-LH and anti-hCG antibodies. At the end of the study, no patients showed the presence of antibodies. Conclusion: The results of this study suggest that repeated treatment cycles with FSH or hMG in patients undergoing COS for in vitro fertilization can be safely and effectively applied without concerns for immunogenicity.

KW - ADA

KW - antibodies

KW - FSH

KW - hCG

KW - LH

UR - http://www.scopus.com/inward/record.url?scp=85017200682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017200682&partnerID=8YFLogxK

U2 - 10.1111/aji.12675

DO - 10.1111/aji.12675

M3 - Article

C2 - 28378950

AN - SCOPUS:85017200682

VL - 78

JO - American Journal of Reproductive Immunology

JF - American Journal of Reproductive Immunology

SN - 8755-8920

IS - 3

M1 - e12675

ER -